Marksans Pharma Launches Omeprazole Tablets

  Published 10 months ago

Marksans Pharma introduced bioequivalent Omeprazole 20 mg tablets, matching Prilosec OTC, for heartburn and acid-related disorder treatment.

  • Omeprazole is a proton pump inhibitor effective in treating GERD, dyspepsia, and heartburn by reducing excess stomach acid.
  • Product matches reference drug Prilosec OTC 20 mg, marketed by AstraZeneca under NDA 021229, ensuring equivalent efficacy and safety.
  • Marksans operates globally with USFDA, UKMHRA, and TGA-approved facilities, offering a diversified portfolio across multiple therapeutic segments.

You might like these

India’s August Private Sector Boom

India's Net Non-Resident Claims Drop to $330 Billion in Q4 2024-25

India's Forex Reserves Surge to Near Record High

Amber’s IL JIN Acquires Unitronics

Bajaj Healthcare: Manufacturing Overview

NMDC Shares Fall 3% After Iron Ore Price Cut Effective July 1

HUL Q2 Dip Sparks Volume Strategy Shift

News that matters the most ⚡